These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 27677788)

  • 1. Exposing the Three-Dimensional Biogeography and Metabolic States of Pathogens in Cystic Fibrosis Sputum via Hydrogel Embedding, Clearing, and rRNA Labeling.
    DePas WH; Starwalt-Lee R; Van Sambeek L; Ravindra Kumar S; Gradinaru V; Newman DK
    mBio; 2016 Sep; 7(5):. PubMed ID: 27677788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum.
    Kolpen M; Kragh KN; Bjarnsholt T; Line L; Hansen CR; Dalbøge CS; Hansen N; Kühl M; Høiby N; Jensen PØ
    Int J Med Microbiol; 2015 Jan; 305(1):1-10. PubMed ID: 25441256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Visualization of Gene Expression in Mucoid and Nonmucoid Pseudomonas aeruginosa Aggregates Reveals Localized Peak Expression of Alginate in the Hypoxic Zone.
    Jorth P; Spero MA; Livingston J; Newman DK
    mBio; 2019 Dec; 10(6):. PubMed ID: 31848278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of correlation between
    Morris AJ; Yau YC; DePas WH; Waters VJ
    Heliyon; 2024 Jun; 10(11):e32424. PubMed ID: 38933957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Modeling of Cystic Fibrosis Airway Communities Predicts Mechanisms of Pathogen Dominance.
    Henson MA; Orazi G; Phalak P; O'Toole GA
    mSystems; 2019; 4(2):. PubMed ID: 31020043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RISA-HPLC analysis of lung bacterial colonizers of cystic fibrosis children.
    Nazaret S; Assade F; Brothier E; Freydière AM; Bellon G; Cournoyer B
    J Microbiol Methods; 2009 Jan; 76(1):58-69. PubMed ID: 18929602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections.
    Heirali A; McKeon S; Purighalla S; Storey DG; Rossi L; Costilhes G; Drews SJ; Rabin HR; Surette MG; Parkins MD
    PLoS One; 2016; 11(2):e0148534. PubMed ID: 26859493
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Kiedrowski MR; Gaston JR; Kocak BR; Coburn SL; Lee S; Pilewski JM; Myerburg MM; Bomberger JM
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30111629
    [No Abstract]   [Full Text] [Related]  

  • 9.
    Orazi G; O'Toole GA
    mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients.
    van Belkum A; Renders NH; Smith S; Overbeek SE; Verbrugh HA
    FEMS Immunol Med Microbiol; 2000 Jan; 27(1):51-7. PubMed ID: 10617790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Airway Colonization by Achromobacter xylosoxidans in Cystic Fibrosis Patients Is Not Sustained by Their Domestic Environment.
    Dupont C; Jumas-Bilak E; Doisy C; Aujoulat F; Chiron R; Marchandin H
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217850
    [No Abstract]   [Full Text] [Related]  

  • 12. Trace incorporation of heavy water reveals slow and heterogeneous pathogen growth rates in cystic fibrosis sputum.
    Kopf SH; Sessions AL; Cowley ES; Reyes C; Van Sambeek L; Hu Y; Orphan VJ; Kato R; Newman DK
    Proc Natl Acad Sci U S A; 2016 Jan; 113(2):E110-6. PubMed ID: 26715741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High individuality of respiratory bacterial communities in a large cohort of adult cystic fibrosis patients under continuous antibiotic treatment.
    Kramer R; Sauer-Heilborn A; Welte T; Jauregui R; Brettar I; Guzman CA; Höfle MG
    PLoS One; 2015; 10(2):e0117436. PubMed ID: 25671713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Detection of Emerging Pathogens and Loss of Microbial Diversity Associated with Severe Lung Disease in Cystic Fibrosis.
    Flight WG; Smith A; Paisey C; Marchesi JR; Bull MJ; Norville PJ; Mutton KJ; Webb AK; Bright-Thomas RJ; Jones AM; Mahenthiralingam E
    J Clin Microbiol; 2015 Jul; 53(7):2022-9. PubMed ID: 25878338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage Inhibit Pathogen Dissemination by Targeting Bacterial Migrants in a Chronic Infection Model.
    Darch SE; Kragh KN; Abbott EA; Bjarnsholt T; Bull JJ; Whiteley M
    mBio; 2017 Apr; 8(2):. PubMed ID: 28377527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008.
    Emerson J; McNamara S; Buccat AM; Worrell K; Burns JL
    Pediatr Pulmonol; 2010 Apr; 45(4):363-70. PubMed ID: 20232473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Occurrence of Bacterial Competition Among Clinically Documented Opportunistic Pathogens Including
    Menetrey Q; Dupont C; Chiron R; Jumas-Bilak E; Marchandin H
    Front Microbiol; 2020; 11():558160. PubMed ID: 33013789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology.
    Palmer KL; Mashburn LM; Singh PK; Whiteley M
    J Bacteriol; 2005 Aug; 187(15):5267-77. PubMed ID: 16030221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
    BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections.
    Yang L; Haagensen JA; Jelsbak L; Johansen HK; Sternberg C; Høiby N; Molin S
    J Bacteriol; 2008 Apr; 190(8):2767-76. PubMed ID: 18156255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.